The Sunday newspapers were given a "free" mega story when AstraZeneca announced its $40 billion takeover of US-based Alexion Pharmaceuticals on Saturday. So, naturally I thought they would all lead their respective business section front pages on the biggest pharma deal of the year carried out by a FTSE 100-listed company...
So...there was no statement from AstraZeneca this morning regarding Gilead.
And both the The Times and The Daily Telegraph appear to be poring cold water on the prospect of $200 billion plus merger, which was unveiled yesterday by Bloomberg. Below is the link to The Times report:..
There is a big story breaking on Bloomberg right now about AstraZeneca trying to buy Gilead to create a $200 billion pharmaceutical giant. Below is the link:..
So, the cat is finally out of the bag at Circassia Pharmaceuticals: the company announced this morning that it would cancel the agreement with AstraZeneca for the US commercial rights to Tudorza and Duaklir in return for the FTSE 100 giant writing off a $150 million loan...